"Papillomavirus Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.
| Descriptor ID |
D053918
|
| MeSH Number(s) |
D20.215.894.899.498
|
| Concept/Terms |
Human Papillomavirus Vaccines- Human Papillomavirus Vaccines
- Papillomavirus Vaccines, Human
- Vaccines, Human Papillomavirus
- Human Papilloma Virus Vaccines
- HPV Vaccines
|
Below are MeSH descriptors whose meaning is more general than "Papillomavirus Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Papillomavirus Vaccines".
This graph shows the total number of publications written about "Papillomavirus Vaccines" by people in this website by year, and whether "Papillomavirus Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 2 | 3 |
| 2009 | 6 | 1 | 7 |
| 2010 | 2 | 0 | 2 |
| 2011 | 4 | 0 | 4 |
| 2012 | 3 | 1 | 4 |
| 2013 | 4 | 1 | 5 |
| 2014 | 5 | 0 | 5 |
| 2015 | 6 | 1 | 7 |
| 2016 | 13 | 1 | 14 |
| 2017 | 11 | 4 | 15 |
| 2018 | 8 | 5 | 13 |
| 2019 | 8 | 5 | 13 |
| 2020 | 9 | 2 | 11 |
| 2021 | 12 | 1 | 13 |
| 2022 | 14 | 0 | 14 |
| 2023 | 9 | 0 | 9 |
| 2024 | 7 | 0 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Papillomavirus Vaccines" by people in Profiles.
-
Effects of religion, politics and distance to providers on HPV vaccine attitudes and intentions of parents in rural Utah. PLoS One. 2024; 19(10):e0312549.
-
Human Papillomavirus Vaccination and Human Papillomavirus-Related Cancer Rates. JAMA Netw Open. 2024 Sep 03; 7(9):e2431807.
-
A multilevel intervention to promote HPV vaccination among young adults in Texas: protocol for a randomized controlled trial. BMC Public Health. 2024 Jun 05; 24(1):1506.
-
Effect of age at initiation of the human papillomavirus vaccine on the association between race/ethnicity and completion of the vaccine series. Vaccine. 2024 Apr 19; 42(11):2827-2836.
-
A Randomized Study to Determine the Effect of a Culturally Focused Video Intervention on Improving HPV Vaccine Intentions in a Christian Population in the United States. J Community Health. 2024 Aug; 49(4):661-673.
-
Human Papillomavirus Vaccination Among Young Adults Before and During the COVID-19 Pandemic. JAMA Netw Open. 2024 02 05; 7(2):e2356875.
-
HPV vaccination in Africa in the COVID-19 era: a cross-sectional survey of healthcare providers' knowledge, training, and recommendation practices. Front Public Health. 2024; 12:1343064.
-
Barriers and determinants of consistent offering of HPV vaccination by healthcare facilities. Hum Vaccin Immunother. 2023 08; 19(2):2264596.
-
Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention. Cancer Prev Res (Phila). 2023 09 01; 16(9):483-495.
-
Barriers to human papillomavirus vaccine uptake: role of state religiosity and healthcare professionals' participation in a state vaccine program. JNCI Cancer Spectr. 2023 08 31; 7(5).